Should we abandon the term 〝lone atrial fibrillation〞?

Ryder, 1999, Epidemiology and significance of atrial fibrillation, Am J Cardiol, 84, 131R, 10.1016/S0002-9149(99)00713-4 Lloyd-Jones, 2004, Lifetime risk for development of atrial fibrillation: the Framingham Heart Study, Circulation, 110, 1042, 10.1161/01.CIR.0000140263.20897.42 Furberg, 1994, Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study), Am J Cardiol, 74, 236, 10.1016/0002-9149(94)90363-8 Kirchhof, 2017, 2016 ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration With EACTS, Rev Esp Cardiol, 70, 50 Evans, 1954, Lone auricular fibrillation, Br Heart J, 16, 189, 10.1136/hrt.16.2.189 Camm, 2010, Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC), Eur Heart J, 31, 2369, 10.1093/eurheartj/ehq278 Wyse, 2014, Lone atrial fibrillation: does it exist?, J Am Coll Cardiol, 63, 1715, 10.1016/j.jacc.2014.01.023 Wakili, 2011, Recent advances in the molecular pathophysiology of atrial fibrillation, J Clin Invest, 121, 2955, 10.1172/JCI46315 Goette, 2016, EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication, Europace, 18, 1455, 10.1093/europace/euw161 Cui, 2018, Atrial remodeling and metabolic dysfunction in idiopathic isolated fibrotic atrial cardiomyopathy, Int J Cardiol, 265 Schotten, 2011, Pathophysiological mechanisms of atrial fibrillation: a translational appraisal, Physiol Rev, 91, 265, 10.1152/physrev.00031.2009 Allessie, 2001, Pathophysiology and prevention of atrial fibrillation, Circulation, 103, 769, 10.1161/01.CIR.103.5.769 Kanmanthareddy, 2015, Lone atrial fibrillation: electrophysiology, risk factors, catheter ablation and other non-pharmacologic treatments, Curr Pharmaceut Des, 21, 580, 10.2174/1381612820666140825130524 Todd, 2003, Role of the posterior left atrium and pulmonary veins in human lone atrial fibrillation: electrophysiological and pathological data from patients undergoing atrial fibrillation surgery, Circulation, 108, 3108, 10.1161/01.CIR.0000104567.72914.BF Stiles, 2009, Paroxysmal lone atrial fibrillation is associated with an abnormal atrial substrate: characterizing the "second factor, J Am Coll Cardiol, 53, 1182, 10.1016/j.jacc.2008.11.054 Arora, 2003, Arrhythmogenic substrate of the pulmonary veins assessed by high-resolution optical mapping, Circulation, 107, 1816, 10.1161/01.CIR.0000058461.86339.7E Melnyk, 2005, Comparison of ion channel distribution and expression in cardiomyocytes of canine pulmonary veins versus left atrium, Cardiovasc Res, 65, 104, 10.1016/j.cardiores.2004.08.014 Dobrev, 2005, The G protein-gated potassium current I(K,ACh) is constitutively active in patients with chronic atrial fibrillation, Circulation, 112, 3697, 10.1161/CIRCULATIONAHA.105.575332 Van Wagoner, 1999, Atrial L-type Ca2+ currents and human atrial fibrillation, Circ Res, 85, 428, 10.1161/01.RES.85.5.428 Perez-Lugones, 2003, Evidence of specialized conduction cells in human pulmonary veins of patients with atrial fibrillation, J Cardiovasc Electrophysiol, 14, 803, 10.1046/j.1540-8167.2003.03075.x Nattel, 2012, The multidimensional role of calcium in atrial fibrillation pathophysiology: mechanistic insights and therapeutic opportunities, Eur Heart J, 33, 1870, 10.1093/eurheartj/ehs079 Dai, 2016, Characterization of Ca+ handling proteins and contractile proteins in patients with lone atrial fibrillation, Int J Cardiol, 202, 749, 10.1016/j.ijcard.2015.10.010 Chen, 2006, Electrophysiology of pulmonary veins, J Cardiovasc Electrophysiol, 17, 220, 10.1111/j.1540-8167.2005.00317.x Kumagai, 2004, Electrophysiologic properties of pulmonary veins assessed using a multielectrode basket catheter, J Am Coll Cardiol, 43, 2281, 10.1016/j.jacc.2004.01.051 Nathan, 1966, The junction between the left atrium and the pulmonary veins. An anatomic study of human hearts, Circulation, 34, 412, 10.1161/01.CIR.34.3.412 Frustaci, 1997, Histological substrate of atrial biopsies in patients with lone atrial fibrillation, Circulation, 96, 1180, 10.1161/01.CIR.96.4.1180 Gaspo, 1997, Functional mechanisms underlying tachycardia-induced sustained atrial fibrillation in a chronic dog model, Circulation, 96, 4027, 10.1161/01.CIR.96.11.4027 Youn, 2013, Oxidative stress in atrial fibrillation: an emerging role of NADPH oxidase, J Mol Cell Cardiol, 62, 72, 10.1016/j.yjmcc.2013.04.019 Canpolat, 2017, Relationship between vitamin D level and left atrial fibrosis in patients with lone paroxysmal atrial fibrillation undergoing cryoballoon-based catheter ablation, J Cardiol, 69, 16 Skalidis, 2008, Isolated atrial microvascular dysfunction in patients with lone recurrent atrial fibrillation, J Am Coll Cardiol, 51, 2053, 10.1016/j.jacc.2008.01.055 Oliveira, 2009, Effects of stimulation and blockade of the autonomic nervous system on atrial refractoriness in patients with lone paroxysmal atrial fibrillation, Rev Port Cardiol, 28, 655 Tan, 2008, Neural mechanisms of paroxysmal atrial fibrillation and paroxysmal atrial tachycardia in ambulatory canines, Circulation, 118, 916, 10.1161/CIRCULATIONAHA.108.776203 Yu, 2013, Low-level transcutaneous electrical stimulation of the auricular branch of the vagus nerve: a noninvasive approach to treat the initial phase of atrial fibrillation, Heart Rhythm, 10, 428, 10.1016/j.hrthm.2012.11.019 Andreasen, 2015, Genetic aspects of lone atrial fibrillation: what do we know?, Curr Pharmaceut Des, 21, 667, 10.2174/1381612820666140825143610 Gudbjartsson, 2007, Variants conferring risk of atrial fibrillation on chromosome 4q25, Nature, 448, 353, 10.1038/nature06007 Oyen, 2012, Familial aggregation of lone atrial fibrillation in young persons, J Am Coll Cardiol, 60, 917, 10.1016/j.jacc.2012.03.046 Kalinderi, 2018, PRRX1 Rs3903239 polymorphism and atrial fibrillation in a Greek population, Hellenic J Cardiol, 10.1016/j.hjc.2018.01.005 Wang, 2016, Prevalence and Spectrum of TBX5 Mutation in Patients with Lone Atrial Fibrillation, Int J Med Sci, 13, 60, 10.7150/ijms.13264 Steffensen, 2015, IKs Gain- and Loss-of-Function in Early-Onset Lone Atrial Fibrillation, J Cardiovasc Electr, 26, 715, 10.1111/jce.12666 Donate Puertas, 2017, Atrial fibrillation is associated with hypermethylation in human left atrium and treatment with decitabine reduces atrial tachyarrhythmias in spontaneously hypertensive rats, Arch Cardiovas Dis Suppl Cao, 2014, A functional polymorphism C-509T in TGFβ-1 promoter contributes to susceptibility and prognosis of lone atrial fibrillation in Chinese population, PLoS One, 9, e112912, 10.1371/journal.pone.0112912 Thorolfsdottir, 2017, A Missense Variant in PLEC Increases Risk of Atrial Fibrillation, J Am Coll Cardiol, 70, 2157, 10.1016/j.jacc.2017.09.005 Weeke, 2014, Candidate gene approach to identifying rare genetic variants associated with lone atrial fibrillation, Heart Rhythm Official J Heart Rhythm Soc, 11, 46, 10.1016/j.hrthm.2013.10.025 Paludan-Müller, 2016, The role of common genetic variants in atrial fibrillation, J Electrocardiol, 49, 864, 10.1016/j.jelectrocard.2016.08.012 van den Berg, 2017, MicroRNAs in Atrial Fibrillation: from Expression Signatures to Functional Implications, Cardiovasc Drugs Ther, 31, 345, 10.1007/s10557-017-6736-z Lu, 2010, MicroRNA-328 contributes to adverse electrical remodeling in atrial fibrillation, Circulation, 122, 2378, 10.1161/CIRCULATIONAHA.110.958967 Jia, 2013, MicroRNA-1 accelerates the shortening of atrial effective refractory period by regulating KCNE1 and KCNB2 expression: an atrial tachypacing rabbit model, PLoS One, 8, e85639, 10.1371/journal.pone.0085639 G, 2009, Changes in microRNA-1 expression and IK1 up-regulation in human atrial fibrillation, Heart Rhythm, 6, 1802, 10.1016/j.hrthm.2009.08.035 Nwe, 2017, MicroRNAs in Atrial Fibrillation: from Expression Signatures to Functional Implications, Cardiovasc Drugs Ther, 31, 345, 10.1007/s10557-017-6736-z Zhao, 2007, Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2, Cell, 129, 303, 10.1016/j.cell.2007.03.030 Terentyev, 2009, miR-1 overexpression enhances Ca(2+) release and promotes cardiac arrhythmogenesis by targeting PP2A regulatory subunit B56alpha and causing CaMKII-dependent hyperphosphorylation of RyR2, Circ Res, 104, 514, 10.1161/CIRCRESAHA.108.181651 Zhao, 2015, Post-transcriptional regulation of cardiac sodium channel gene SCN5A expression and function by miR-192-5p, Biochim Biophys Acta, 1852, 2024, 10.1016/j.bbadis.2015.07.016 Adam, 2012, Role of miR-21 in the pathogenesis of atrial fibrosis, Basic Res Cardiol, 107, 278, 10.1007/s00395-012-0278-0 Thum, 2008, MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts, Nature, 456, 980, 10.1038/nature07511 Xiong, 2012, Identification of novel miR-21 target proteins in multiple myeloma cells by quantitative proteomics, J Proteome Res, 11, 2078, 10.1021/pr201079y Conway, 2004, Inflammation, arrhythmia burden and the thrombotic consequences of atrial fibrillation, Eur Heart J, 25, 1761, 10.1016/j.ehj.2004.08.001 Kim, 2011, Female patients with atrial fibrillation have increased oxidized and glycated lipoprotein properties and lower apolipoprotein A-I expression in HDL, Int J Mol Med, 27, 841 Polovina, 2015, Relation of Biomarkers of Inflammation and Oxidative Stress with Hypertension Occurrence in Lone Atrial Fibrillation, Mediat Inflamm, 2015, 1, 10.1155/2015/653026 Lederman, 1992, Identification of a novel surface protein on activated CD4+ T cells that induces contact-dependent B cell differentiation (help), J Exp Med, 175, 1091, 10.1084/jem.175.4.1091 Bozcali, 2016, [Relationship between serum level of CD40 ligand and persistent lone atrial fibrillation], Turk Kardiyol Dernegi Arsivi, 44, 389 Duygu, 2008, Prognostic value of plasma soluble CD40 ligand in patients with chronic non-valvular atrial fibrillation, Europace, 10, 210, 10.1093/europace/eum284 Ferro, 2007, Soluble CD40 ligand predicts ischemic stroke and myocardial infarction in patients with nonvalvular atrial fibrillation, Arteriosclerosis Thrombosis Vascular Biol, 27, 2763, 10.1161/ATVBAHA.107.152777 Hsu, 1999, Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand, P Natl Acad Sci USA, 96, 3540, 10.1073/pnas.96.7.3540 Krakauer, 2008, Nuclear factor-kappaB: fine-tuning a central integrator of diverse biologic stimuli, Int Rev Immunol, 27, 286, 10.1080/08830180802317957 Frustaci, 1997, Histological Substrate of Atrial Biopsies in Patients With Lone Atrial Fibrillation, Circulation, 96, 1180, 10.1161/01.CIR.96.4.1180 Schnabel, 2009, Relation of multiple inflammatory biomarkers to incident atrial fibrillation, Am J Cardiol, 104, 92, 10.1016/j.amjcard.2009.02.053 Yalcin, 2015, Elevated M2-muscarinic and beta1-adrenergic receptor autoantibody levels are associated with paroxysmal atrial fibrillation, Clin Res Cardiol, 104, 226, 10.1007/s00392-014-0776-1 Gurses, 2015, M2-muscarinic acetylcholine receptor autoantibody levels predict left atrial fibrosis severity in paroxysmal lone atrial fibrillation patients undergoing cryoablation, Europace, 17, 239, 10.1093/europace/euu228 Shi, 2006, Proliferation and anti-apoptotic effects of human urotensin II on human endothelial cells, Atherosclerosis, 188, 260, 10.1016/j.atherosclerosis.2005.10.044 Zhang, 2009, Relation of urotensin II levels to lone atrial fibrillation, Am J Cardiol, 104, 1704, 10.1016/j.amjcard.2009.07.053 Watanabe, 2001, Synergistic effect of urotensin II with serotonin on vascular smooth muscle cell proliferation, J Hypertens, 19, 2191, 10.1097/00004872-200112000-00012 Zhang, 2009, Relation of Urotensin II Levels to Lone Atrial Fibrillation, Am J Cardiol, 104, 1704, 10.1016/j.amjcard.2009.07.053 Yoshimoto, 2004, Role of urotensin II in peripheral tissue as an autocrine/paracrine growth factor, Peptides, 25, 1775, 10.1016/j.peptides.2004.03.028 Liao, 2011, Change and significance in the levels of plasma urotensin II and catestatin in children with postural orthostatic tachycardia syndrome, Beijing Da Xue Xue Bao Yi Xue Ban, vol. 43, 436 Joyal, 2006, Urotensin-II levels in acute coronary syndromes, Int J Cardiol, 108, 31, 10.1016/j.ijcard.2005.04.001 Opdenakker, 2001, Gelatinase B functions as regulator and effector in leukocyte biology, J Leukocyte Biol, 69, 851, 10.1189/jlb.69.6.851 Galis, 2002, Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly, Circ Res, 90, 251, 10.1161/res.90.3.251 Li, 2014, Changes in matrix metalloproteinase-9 levels during progression of atrial fibrillation, J Int Med Res, 42, 224 Pellman, 2015, Atrial fibrillation: mechanisms, therapeutics, and future directions, Compr Physiol, 5, 649, 10.1002/cphy.c140047 Kumareswaran, 2015, Utility of anti-arrhythmic medications in 'lone atrial fibrillation, Curr Pharmaceut Des, 21, 573, 10.2174/1381612820666140825145357 Archontakis, 2018, Novel therapeutic options in the prevention of atrial fibrillation, Hellenic J Cardiol, 59, 279, 10.1016/j.hjc.2018.12.001 Yin, 2006, Prospective randomized study comparing amiodarone vs. amiodarone plus losartan vs. amiodarone plus perindopril for the prevention of atrial fibrillation recurrence in patients with lone paroxysmal atrial fibrillation, Eur Heart J, 27, 1841, 10.1093/eurheartj/ehl135 Domenech, 2013, Nighttime ambulatory blood pressure is associated with atrial remodelling and neurohormonal activation in patients with idiopathic atrial fibrillation, Rev Esp Cardiol, 66, 458 Camm, 2012, 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association, Europace, 14, 1385, 10.1093/europace/eus305 Pison, 2014, Work-up and management of lone atrial fibrillation: results of the European Heart Rhythm Association Survey, Europace, 16, 1521, 10.1093/europace/euu277 Cao, 2014, Serum sRANKL/OPG predict recurrence after radiofrequency catheter ablation of lone atrial fibrillation, Int J Cardiol, 170, 298, 10.1016/j.ijcard.2013.08.084 Zhou, 2017, Baseline serum globulin as a predictor of the recurrence of lone atrial fibrillation after radiofrequency catheter ablation, Anatol J Cardiol, 17, 381 DE Regibus, 2016, Second-Generation Cryoballoon Ablation in the Setting of Lone Paroxysmal Atrial Fibrillation: Single Procedural Outcome at 12 Months, J Cardiovasc Electrophysiol, 27, 677, 10.1111/jce.12973 Camm, 2012, 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association, Eur Heart J, 33, 2719, 10.1093/eurheartj/ehs253